
Know your dog. Better.
Embark Veterinary is a canine genomics and biotechnology company based in Boston, Massachusetts, founded in 2015 by brothers Adam and Ryan Boyko. The company offers dog DNA testing services to consumers, breeders, and veterinary practices. Its flagship products screen for over 400 dog breeds and test for hundreds of genetic health conditions, coat color and trait markers, estimated biological age, and a Relative Finder feature that connects dogs sharing DNA. Embark uses a research-grade microarray platform developed in partnership with Cornell University College of Veterinary Medicine, making it one of the most scientifically rigorous consumer dog DNA tests available. The company also offers gut health tests and targeted nutritional supplements. Embark has helped millions of pet parents better understand their dogs' breed ancestry, health risks, and care needs.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountJul 2021
Apr 2019
Jul 2017
May 2016
Create a free account to see which investors have funded this company.
Create Free AccountBiopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Didi Chuxing is a mobile transportation platform, offering a full range of commuting options to 4...

Grab is Southeast Asia's leading super-app, providing ride-hailing, food and grocery delivery, di...

Uber is an app-based transportation company that connects users to drivers and deliveries.